News - Page 233 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Psychedelic Bulletin: MindMed Raises $34.5m; Tryp Goes Public; What Health Canada’s Latest Amendment Means for Psychedelics

Psychedelic Bulletin: MindMed Raises $34.5m; Tryp Goes Public; What Health Canada’s Latest Amendment Means for Psychedelics

Post published:December 18, 2020
Post category:Psychedelic Bulletin

Read more about the article Tryp Therapeutics Begins Trading on the Canadian Securities Exchange

Tryp Therapeutics Begins Trading on the Canadian Securities Exchange

Post published:December 18, 2020
Post category:Press Release

Read more about the article Ehave, Inc. Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021

Ehave, Inc. Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021

Post published:December 17, 2020
Post category:Press Release

Read more about the article MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand

MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand

Post published:December 17, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Completes Initial Public Offering

Tryp Therapeutics Completes Initial Public Offering

Post published:December 17, 2020
Post category:Press Release

Read more about the article Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000

Mindset Pharma Announces Closing of Non-Brokered Private Placement, Increasing Aggregate Gross Proceeds Raised to $5,000,000

Post published:December 17, 2020
Post category:Press Release

Read more about the article Havn Life Sciences Provides Update on Retail Strategy and Product Development

Havn Life Sciences Provides Update on Retail Strategy and Product Development

Post published:December 17, 2020
Post category:Press Release

Read more about the article Jackie von Salm, Co-founder and CSO at Psilera Bioscience

Jackie von Salm, Co-founder and CSO at Psilera Bioscience

Post published:December 17, 2020
Post category:Interview

Read more about the article Numinus Completes First Extraction of its Psilocybe Mushrooms

Numinus Completes First Extraction of its Psilocybe Mushrooms

Post published:December 17, 2020
Post category:Press Release

Read more about the article Havn Life Sciences Hits Major Milestone with Research Partner, Complex Biotech Discovery Ventures

Havn Life Sciences Hits Major Milestone with Research Partner, Complex Biotech Discovery Ventures

Post published:December 17, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.